Registry for patients with myeloid diseases in Austria

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Austrian Myeloid Registry (aMYELOIDr) is a non-interventional observational study that collects data from patients diagnosed with myeloid diseases, including myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). This multi-center registry gathers real-world data from various sites in Austria, with the potential for future expansion to other countries. Data is entered into an electronic case report form (eCRF) by clinical personnel and physicians, aiming to enhance understanding and management of these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>17 years
* Diagnosis of myeloid disease according to WHO 2016
* Signed patient informed consent (IC)

Exclusion Criteria:

* Patient is unable or unwilling to sign IC

Where it's running

• LKH Feldkirch, Innere Medizin II, Interne E: Hämatologie und Onkologie
  Feldkirch, Austria Recruiting
• KH der Barmherzigen Brüder, Innere Medizin I
  Graz, Austria Recruiting
• Universitätsklinik Innsbruck, Univ.-Klinik für Innere Medizin V, Hämatologie und Onkologie
  Innsbruck, Austria Recruiting
• Universitätsklinikum Krems, Innere Medizin II Hämato-Onkologie
  Krems, Austria Recruiting
• LKH Hochsteiermark, Abteilung für Hämato-Onkologie
  Leoben, Austria Recruiting
• Ordensklinikum Linz GmbH, Barmherzige Schwestern, Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie
  Linz, Austria Recruiting

Study contacts

• Principal investigator: Lisa Pleyer, MD — 3rd Med Dept Paracelsus Medical University, Salzburg
• Study coordinator: Lisa Pleyer, MD
• Email: dr.lisa.pleyer@gmail.com
• Phone: +43676899758271

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for patients with advanced metastatic colorectal cancer

  This study is collecting information from patients with advanced colorectal cancer who have tried different treatments to see how well they are doing and to help improve future care.

  Recruiting at 7 sites Arbeitsgemeinschaft medikamentoese Tumortherapie · Linz and 6 other locations · NCT06678919

• A registry for patients with lymphoma

  This study is collecting information from lymphoma patients to see how they are diagnosed, treated, and how they do over time, all while making sure their regular care isn't affected.

  Recruiting Arbeitsgemeinschaft medikamentoese Tumortherapie · Salzburg, State of Salzburg · NCT06294652

• Registry for metastatic breast cancer in Austria

  This study is collecting information from people with metastatic breast cancer in Austria to better understand the disease and how different treatments are working.

  Recruiting at 16 sites Arbeitsgemeinschaft medikamentoese Tumortherapie · Salzburg, State of Salzburg and 15 other locations · NCT03870620

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.